Fund performance: Union Square, OrbiMed, TCV top mid-life venture portfolioByMark Boslet7 June 2017•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.FeaturedFundraisingInvestorsManagersFeaturedFundraisingInvestor PerformancePerformance